NCT06056726

Brief Summary

Obesity worsens treatment outcomes in rectal cancer patients: the local resective approach could in fact be more difficult in obese patients due to limited surgical visibility and it has also been reported that high visceral adiposity determines an increased risk of recurrence after chemoradiotherapy neoadjuvant. Bariatric surgery has proved to be the best choice for the treatment of morbid obesity and related comorbidities and in this context, the intragastric balloon (IGB) represents a strategy characterized by a low rate of complications and good results in terms of weight loss. Therefore, the need to be able to offer obese patients suffering from rectal cancer the possibility of a better recovery perspective, alongside radical oncological surgery and neoadjuvant treatments, also a bariatric surgery such as the positioning of an intragastric balloon.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2021

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

September 21, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2025

Completed
Last Updated

September 29, 2023

Status Verified

September 1, 2023

Enrollment Period

3 years

First QC Date

September 21, 2023

Last Update Submit

September 27, 2023

Conditions

Keywords

Bariatric SurgeryOncological surgery

Outcome Measures

Primary Outcomes (1)

  • Peri-operative complications

    Peri-operative complications during rectal cancer surgery

    Intra-operative complications and complications within 30 days from surgery

Secondary Outcomes (1)

  • Overall survival

    3 years after surgery

Study Arms (1)

Obese Patients

Patients candidates for resective surgery for rectal cancer and also elegible for bariatric surgery

Procedure: BIB positioning

Interventions

BIB positioning in obese patients with rectal cancer elegible for neoadjuvant therapy

Obese Patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Obese patients, with locally advanced rectal cancer in clinical stage II-III, candidates for neoadjuvant therapy, who can underwent BIB positioning during neoadjuvant period to obtain weight loss before resective cancer surgery

You may qualify if:

  • Patients with locally advanced rectal cancer in clinical stage II-III according to AJCC-UICC 2017 (candidates for neoadjuvant therapy)
  • Patients suffering from I, II and III degree obesity at the same time
  • Age between 18 and 70 years old
  • BMI between 31 and 55 kg/m2
  • Non-Smoking
  • Candidates, according to AIOM guidelines, for rectal resection surgical procedures
  • Candidates, according to SICOB guidelines, for an intragastric balloon placement procedure

You may not qualify if:

  • Age ≤ 18 or ≥ 70 years
  • BMI ≤ 30 or ≥ 59 Kg/m2
  • Smoker
  • Patients with non-locally advanced rectal cancer, not eligible for neoadjuvant therapy
  • Histological positivity to Helicobacter pylori
  • Presence of ulcerative lesions on EGD
  • Previous bariatric surgery treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nunzio Velotti

Naples, 80131, Italy

RECRUITING

MeSH Terms

Conditions

Obesity, MorbidRectal Neoplasms

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

Mario Musella, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Surgery

Study Record Dates

First Submitted

September 21, 2023

First Posted

September 28, 2023

Study Start

February 18, 2021

Primary Completion

February 18, 2024

Study Completion

February 18, 2025

Last Updated

September 29, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations